Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H11N3O4S |
| Molecular Weight | 305.309 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SC=C(N1C(=O)\C2=C\C3=CN4CCOCC4=N3)C(O)=O
InChI
InChIKey=DMEYZPJEFHGESJ-CPWLGJMPSA-N
InChI=1S/C13H11N3O4S/c17-11-8(12-16(11)9(6-21-12)13(18)19)3-7-4-15-1-2-20-5-10(15)14-7/h3-4,6,12H,1-2,5H2,(H,18,19)/b8-3-/t12-/m1/s1
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489. | 2009 Feb |
|
| Relationship between β-lactamase production and resistance phenotype in Klebsiella pneumoniae strains. | 2017 Jul 6 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60212945
Created by
admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
|
PRIMARY | |||
|
9972353
Created by
admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
|
PRIMARY | |||
|
635322-76-8
Created by
admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
|
PRIMARY | |||
|
156B510BCG
Created by
admin on Fri Dec 15 16:23:40 GMT 2023 , Edited by admin on Fri Dec 15 16:23:40 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
